Esophagus or stomach cancer registry for treatment and outcomes
Part of Digestive system clinical trials.
This trial is a cancer data and blood-sample registry. It collects information from people newly diagnosed with esophagus or stomach (or the stomach–esophagus junction) cancer to help researchers understand treatment patterns and outcomes.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have esophagus cancer, stomach cancer, or cancer where the esophagus meets the stomach
- You are age 18 or older
- You are not receiving treatment yet for this cancer (or you have not been treated fully; if you already had neoadjuvant treatment, that may still count)
- You can speak French well enough to participate in the study
- You agree to sign consent for blood samples, questionnaires, and sharing medical information
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial studies how well “liquid biopsy” blood tests can work in people with newly diagnosed, operable esophageal cancer. It may help doctors monitor the cancer and guide treatment planning alongside standard care.
This study keeps an organized record of people diagnosed with esophagus, gastroesophageal junction, or stomach cancer. It helps researchers learn from real-world outcomes, based on health information collected over time.
This study enrolls healthy adults to build a registry and biobank (collection of samples). It tests whether collecting information and biological samples from people without symptoms can help researchers understand normal stomach and esophagus function.
This study looks at stomach (gastric) and esophagus cancer, using clinical information and tissue samples. It may help researchers better understand these cancers and improve future care.
This study collects information and, if you already need blood tests or procedures, may take extra small tissue samples (biopsies) to better understand esophageal-related conditions. It may help researchers learn about risk and future management for people with certain esophagus or reflux-related diagnoses.
This study is looking for people newly diagnosed with esophageal cancer or cancer at the stomach-esophagus junction who are planning to have surgery. The goal is to see if certain noninvasive tests (like scans) can help predict how the disease will progress.
Hear when a new Esophageal Disease trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.